Your browser doesn't support javascript.
loading
The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.
Bagatini, Margarete Dulce; Dos Santos, Alessandra Antunes; Cardoso, Andréia Machado; Mânica, Aline; Reschke, Cristina Ruedell; Carvalho, Fabiano Barbosa.
Afiliação
  • Bagatini MD; Coordenação Acadêmica, Universidade Federal da Fronteira Sul, Campus Chapecó, Chapecó, SC, Brazil.
  • Dos Santos AA; Programa de Pós-graduação em Ciências Biológicas-Bioquímica Toxicológica, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
  • Cardoso AM; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Mânica A; Coordenação Acadêmica, Universidade Federal da Fronteira Sul, Campus Chapecó, Chapecó, SC, Brazil.
  • Reschke CR; Programa de Pós-graduação em Ciências Biológicas-Bioquímica Toxicológica, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
  • Carvalho FB; Programa de Pós-graduação em Ciências Biológicas-Bioquímica Toxicológica, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
J Immunol Res ; 2018: 4892473, 2018.
Article em En | MEDLINE | ID: mdl-30159340
Evidences show that purinergic signaling is involved in processes associated with health and disease, including noncommunicable, neurological, and degenerative diseases. These diseases strike from children to elderly and are generally characterized by progressive deterioration of cells, eventually leading to tissue or organ degeneration. These pathological conditions can be associated with disturbance in the signaling mediated by nucleotides and nucleosides of adenine, in expression or activity of extracellular ectonucleotidases and in activation of P2X and P2Y receptors. Among the best known of these diseases are atherosclerosis, hypertension, cancer, epilepsy, Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). The currently available treatments present limited effectiveness and are mostly palliative. This review aims to present the role of purinergic signaling highlighting the ectonucleotidases E-NTPDase, E-NPP, E-5'-nucleotidase, and adenosine deaminase in noncommunicable, neurological, and degenerative diseases associated with the cardiovascular and central nervous systems and cancer. In conclusion, changes in the activity of ectonucleotidases were verified in all reviewed diseases. Although the role of ectonucleotidases still remains to be further investigated, evidences reviewed here can contribute to a better understanding of the molecular mechanisms of highly complex diseases, which majorly impact on patients' quality of life.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Receptores Purinérgicos / Doenças Neurodegenerativas / Neoplasias / Nucleotidases Aspecto: Patient_preference Limite: Animals / Humans Idioma: En Revista: J Immunol Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Egito
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Receptores Purinérgicos / Doenças Neurodegenerativas / Neoplasias / Nucleotidases Aspecto: Patient_preference Limite: Animals / Humans Idioma: En Revista: J Immunol Res Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: Egito